Evaluation of policies to support drug development in New Zealand-Reference-Cited by-同舟云学术

Evaluation of policies to support drug development in New Zealand

Published:2010-07 Issue:2 Volume:96 Page:108-117
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Lockhart Michelle,Babar Zaheer Ud-Din,Garg Sanjay

Publisher

Elsevier BV

Subject

Health Policy

Reference60 articles.

1. The dynamics of technological innovation: the case of the pharmaceutical industry;Achilladelis;Research Policy,2001

2. Verband Forschender Arznemittelhersteller e.V. [German Association of Research-based Pharmaceutical Companies]. The Pharmaceutical Industry in Germany—Statistics 2008; 2008.

3. Grabowski H. Are the economics of pharmaceutical research and development changing? Productivity, patents and political pressures. PharmacoEconomics 2004;22:15–24.

4. Challenges faced by the pharmaceutical industry: training graduates for employment in pharmaceutical R&D;Mooney;European Journal of Pharmaceutical Sciences,2001

5. Pharmaceutical economics and policy;Schweitzer,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STRATEGIES OF EMERGING COUNTRIES TO EXPAND THE OPERATIONS TO THE GLOBAL MARKET OF BIOPHARMACEUTICALS;INDIAN DRUGS;2021-08-17

2. Impact of the Trade-Related Aspect of Intellectual Property Rights Agreement on Pharmaceutical Industry in Developing Countries: A Scoping Review;IRAN J PHARM RES;2021

3. A policy-making strategy to forecast outcomes of drug development in Indonesia;International Journal of Health Governance;2020-03-26

4. A predictive policy model to forecast outcomes of drug development in developing countries;International Journal of Health Governance;2019-05-22

5. Did relaxing clinical trial regulation enhance the stock of scientific knowledge in India? Not necessarily;PLOS ONE;2019-01-03